Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$61.15

-1.10 (-1.77%)

As of Sep 23, 9:31 PM ET ·

Financial Highlights (FY 2026)

Revenue

48.28B

Net Income

7.07B

Gross Margin

72.6%

Profit Margin

14.6%

Rev Growth

+1.5%

D/E Ratio

2.44

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	72.6%	72.6%	59.2%	59.2%
Operating Margin	21.5%	19.3%	22.1%	21.3%
Profit Margin	14.6%	13.9%	20.8%	23.5%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	48.28B	47.59B	47.91B	45.13B
Gross Profit	35.06B	34.56B	28.35B	26.71B
Operating Income	10.38B	9.21B	10.61B	9.60B
Net Income	7.07B	6.27B	9.95B	10.61B
Gross Margin	72.6%	72.6%	59.2%	59.2%
Operating Margin	21.5%	19.3%	22.1%	21.3%
Profit Margin	14.6%	13.9%	20.8%	23.5%
Rev Growth	+1.5%	+1.5%	+15.6%	-1.5%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	45.69B	45.69B	44.69B	49.22B
Total Equity	18.71B	18.71B	47.12B	45.92B
D/E Ratio	2.44	2.44	0.95	1.07

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	13.71B	12.83B	15.42B	13.24B
Free Cash Flow	—	—	6.08B	6.45B